DOCSLIB.ORG

Mutations in TRPV4 Cause Charcot-Marie-Tooth Disease Type 2C

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mutations in TRPV4 Cause Charcot-Marie-Tooth Disease Type 2C LETTERS Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C Guida Landouré1–4,12, Anselm A Zdebik1,2,12, Tara L Martinez5,6, Barrington G Burnett3, Horia C Stanescu1,2, Hitoshi Inada7, Yijun Shi3, Addis A Taye3, Lingling Kong5, Clare H Munns8,9, Shelly S Choo7, Christopher B Phelps7, Reema Paudel10, Henry Houlden10, Christy L Ludlow11, Michael J Caterina8,9, Rachelle Gaudet7, Robert Kleta1,2,13, Kenneth H Fischbeck3,13 & Charlotte J Sumner5,13 Charcot-Marie-Tooth disease type 2C (CMT2C) is an We examined subjects from two large families with CMT type autosomal dominant neuropathy characterized by limb, 2C (CMT2C) (Table 1 and Fig. 1a–f), one of which was previously diaphragm and laryngeal muscle weakness. Two unrelated reported2. As described in prior studies2–4, affected individuals families with CMT2C showed significant linkage to showed evidence of a motor greater than sensory axonal neuropathy, chromosome 12q24.11. We sequenced all genes in this causing progressive weakness of distal limb, diaphragm and laryngeal region and identified two heterozygous missense mutations muscles (Table 1). Few affected individuals complained of sensory in the TRPV4 gene, C805T and G806A, resulting in the loss, but all had reduced or absent tendon reflexes. The age of onset amino acid substitutions R269C and R269H. TRPV4 is a and severity of disease were highly variable (Table 1 and Fig. 1a). well-known member of the TRP superfamily of cation Most affected individuals reported a worsening of hand weakness in channels. In TRPV4-transfected cells, the CMT2C mutations the cold. Bilateral sensorineural hearing loss was documented in ten caused marked cellular toxicity and increased constitutive subjects, and nine subjects complained of bladder urgency and incon- and activated channel currents. Mutations in TRPV4 tinence. Muscle and nerve biopsies in a severely affected individual were previously associated with skeletal dysplasias. Our showed marked neurogenic atrophy of the gastrocnemius muscle, findings indicate that TRPV4 mutations can also cause indicating severe loss of muscle innervations (Fig. 1b) and modest a degenerative disorder of the peripheral nerves. The loss of sensory axons in the sural nerve with rare axons undergoing CMT2C-associated mutations lie in a distinct region of the degeneration (Fig. 1c–e). TRPV4 ankyrin repeats, suggesting that this phenotypic Fine mapping analysis in both families showed significant linkage © 2010 Nature America, Inc. All rights reserved. All rights Inc. America, Nature © 2010 variability may be due to differential effects on regulatory to chromosome 12q24.11–12q24.21 (log10 of odds (lod) scores 3.1 protein-protein interactions. and 6.9, respectively), confirming the findings of previous studies4,5. Haplotype reconstruction matched the disease status in all clinically Motor and sensory peripheral nerve cells are highly specialized, affected subjects. Two individuals in family 1 carried the disease allele with long axons that connect the spinal cord with the periphery. but were not found to be affected during limited examination in their Like all neurons, these cells are excitable and depend on ion channels homes. Combined data from families 1 and 2 narrowed the region for multiple functions, including action-potential propagation, syn- of interest to a 2.6-Mb interval between the markers D12S105 and aptic transmission, plasticity and cell survival. Charcot-Marie-Tooth D12S1343 (Fig. 1g). SNP array analysis showed no duplications or (CMT) disease (or hereditary motor and sensory neuropathy, HMSN) deletions in this region (data not shown). is a heterogeneous group of degenerative peripheral nerve disorders Sequencing of all 38 predicted protein-coding genes in the region that together constitute the most common inherited neurological of interest revealed heterozygous nucleotide variants C805T and disease, with an incidence of 1 in 2,500 (ref. 1). In CMT, progressive G806A in exon 5 of the transient receptor potential vanilloid 4 axonal degeneration and cell death result in disabling muscle weak- (TRPV4) gene in affected family members of families 1 and 2, ness and sensory loss. respectively (Fig. 1h). These sequence variants were not present 1Department of Medicine and 2Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK. 3Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA. 4Service de Neurologie, Centre Hospitalo- Universitaire du Point ‘G’, Université de Bamako, Bamako, Mali. 5Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA. 6W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 7Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA. 8Department of Biological Chemistry and 9Department of Neuroscience, Center of Sensory Biology, Johns Hopkins University, Baltimore, Maryland, USA. 10University College London, Institute of Neurology, London, UK. 11Laboratory of Neural Bases of Communication and Swallowing, James Madison University, Harrisonburg, Virginia, USA. 12These authors contributed equally to this work. 13These authors jointly directed the project. Correspondence should be addressed to C.J.S. ([email protected]). Received 5 October; accepted 3 December; published online 27 December 2009; doi:10.1038/ng.512 170 VOLUME 42 | NUMBER 2 | FEBRUARY 2010 NATURE GENETICS LETTERS Table 1 Phenotypic characteristics of subjects with CMT2C Age of Limb weakness Patient Age (yr) Sex onset (yr) First symptom Vocal fold paresis Proximal Distal Sensory loss Hearing loss F1 III2 71 F 44 Foot weakness Mild None Moderate Minimal Yes F1 IV2 48 F 5 Foot weakness Moderate Mild Severe Mild No F1 IV3 46 F 5 Stridor Moderate Mild Moderate Mild No F1 IV4 44 F 3 Foot weakness Severe Severe Severe Moderate Yes F1 V1 24 F 7 Foot weakness ND None Mild Mild No F1 V3 20 F 5 Stridor ND None Mild Mild No F1 V8 18 M 2 Stridor Severe None Mild Minimal No F2 III11 65 M 57 Hearing loss Mild None Mild Minimal Yes F2 III18 61 M 34 Foot weakness Mild Mild Moderate Minimal Yes F2 III22 64 F 35 Foot weakness Mild Mild Severe Minimal Yes F2 III23 57 F 22 Foot weakness Moderate None Mild Minimal Yes F2 III24 49 F <2 Stridor Moderate Mild Moderate Mild Yes F2 IV2 50 M 16 Hoarseness Mild Mild Moderate Mild Yes F2 IV5 53 M 28 Hoarseness Moderate None Mild Minimal Yes F2 IV9 31 F 5 Stridor Moderate None Mild None No F2 IV10 29 M 5 Hoarseness Moderate None Mild Minimal Yes F2 IV12 29 F 2 Stridor Severe Moderate Severe Mild No ND, not determined. in 209 ethnically matched unaffected control individuals. The identi- other families with a CMT2C-like phenotype failed to identify fied mutations predict substitutions at the same amino acid (R269C any mutations, and in one, linkage to chromosome 12q24.11 was and R269H) in the TRPV4 protein. This residue is conserved across excluded, suggesting that CMT2C may be genetically heterogeneous multiple vertebrate species (Fig. 1i). Sequencing of TRPV4 in two (Supplementary Fig. 1). Figure 1 Phenotypic and genetic a F1.III.2 F1.IV.4 b c characteristics of CMT2C. (a) Marked variability of disease severity is demonstrated by mild, late-onset weakness in subject F1.III.2, but severe quadriparesis and respiratory failure in her daughter, subject d e F1.IV.4. Written consent was obtained to publish these photographs. (b) Light microscope images of hematoxylin and eosin-stained sections of gastrocnemius muscle biopsy from subject F1.IV.4 © 2010 Nature America, Inc. All rights reserved. All rights Inc. America, Nature © 2010 demonstrating profound denervation atrophy f Family 1 1 2 Family 2 1 2 of muscle. Scale bar, 10 µm. (c) Toluidine I. I. blue–stained section of sural nerve shows mild loss of large, myelinated sensory 1* 2 3 4 5 6 1 2 3 4 5 6 7 8 9* II. axons. Scale bar, 10 µm. (d) Electron II. microscopy of sural nerve confirms mild loss of large and small myelinated axons 1* 2* 3 4* 5* 1 2 3 4 56* 7* 8 9 10 11*12*13*14* 15 16* 1718* 19 20* 2122*23*24* III. III. and unmyelinated axons. Scale bar, 10 µm. (e) Arrow demonstrates a rare axon undergoing 1* 2* 3* 4* 5* 6* 7* 1* 2* 3 4 5* 6* 7* 8* 9* 10* 11* 12* Wallerian-like axonal degeneration. Scale IV. IV. bar, 2 µm. (f) Pedigrees of families 1 and 2 demonstrating affected subjects in each 1* 2* 3* 4* 5* 6* 7* 8* 9*10*11* of three generations. White, unaffected; V. V. 1* black, affected; gray, unknown disease status. *Sample collected. (g) The haplotypes for g h Control i subjects F1.V.3 and F2.IV.12 are shown. TRPV4 * Family 1 defines the lower border (marker F1V3 F2IV12 Homo KHYVELLVAQGADVHAQARGRFFQPKDEG Family 1 KHYVELLVAQGADVHAQACGRFFQPKDEG D12S1343) and family 2 defines the D12S84 6 7 Family 2 KHYVELLVAQGADVHAQAHGRFFQPKDEG upper border (marker D12S105) of the D12S105 2 1 Family 1 Macaca KHYVELLVAQGADVHAQARGRFFQPKDEG D12S1583 7 5 Rattus KHYVELLVAQGADVHAQARGRFFQPKDEG region of interest. The bracket indicates D12S1339 2 4 Mus KHYVELLVAQGADVHAQARGRFFQPKDEG the linked region. (h) Sequencing shows a D12S1343 2 3 Sus KHYVELLVAQGADVHAQARGRFFQPKDEG D12S1344 1 6 Canis KHYVELLVAQGADVHAQARGRFFQPKDEG heterozygous C805T change in family 1 D12S1616 3 1 Equus KHYVELLVAQGADVHAQARGRFFQPKDEG Bos KHYVELLVAQGADVHAQARGRFFQPKDEG and a G806A change in family 2 in TRPV4. D12S145 2 2 Family 2 (i) Protein homology of TRPV4 in various D12S811 9 6 Monodelphis KHYVELLVAQGADVHAQARGRFFQPKDEG D12S1341 1 6 Gallus KHYVELLVEKGADVHAQARGRFFQPKDEG species. The mutations result in amino D12S354 4 1 Danio KQYVELLVEKGADVHAQARGRFFQPRDEG acid substitutions at Arg269, a highly D12S1023 2 2 Tetraodon KQYVELLVEKGADVHAQARGRFFQPRDEG conserved residue. NATURE GENETICS VOLUME 42 | NUMBER 2 | FEBRUARY 2010 171 LETTERS Figure 2 Mutant TRPV4 causes neuronal a 2.0 d WT R269C R269H toxicity. (a) Quantification of TRPV4 transcript Ex. 3-4 by qRT-PCR in control human lymphoblast 1.5 Ex.
Load more

Recommended publications
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Expression of Transient Receptor Potential Channels in the Ependymal Cells of the Developing Rat Brain
    Original Article http://dx.doi.org/10.5115/acb.2013.46.1.68 pISSN 2093-3665 eISSN 2093-3673 Expression of transient receptor potential channels in the ependymal cells of the developing rat brain Kwang Deog Jo1, Kyu-Seok Lee2, Won Taek Lee3, Mi-Sun Hur2, Ho-Jeong Kim2 1Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, 2Department of Anatomy, Kwandong University College of Medicine, Gangneung, 3Department of Anatomy, Yonsei University College of Medicine, Seoul, Korea Abstract: Cerebrospinal fluid (CSF) plays an important role in providing brain tissue with a stable internal environment as well as in absorbing mechanical and thermal stresses. From its initial composition, derived from the amniotic fluid trapped by the closure of neuropores, CSF is modified by developing and differentiating ependymal cells lining the ventricular surface or forming the choroid plexus. Its osmolarity and ionic composition brings about a change through the action of many channels expressed on the ependymal cells. Some newly discovered transient receptor potential (TRP) channels are known to be expressed in the choroid plexus ependyma. To detect additional TRP channel expression, immunohistochemical screening was performed at the choroid plexus of 13-, 15-, 17-, and 19-day embryos, using antibodies against TRPV1, TRPV3, and TRPA1, and the expression was compared with those in the adult TRP channels. The level of TRP channel expression was higher in the choroid plexus which suggests more active functioning of TRP channels in the developing choroid plexus than the ventricular lining ependyma in the 15- and 17-day embryos. All the expression of TRP channels decreased at the 19th day of gestation.
    [Show full text]
  • Investigational Drugs in Early Phase Clinical Trials Targeting Thermotransient Receptor Potential (Thermotrp) Channels
    Expert Opinion on Investigational Drugs ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ieid20 Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels Asia Fernández-Carvajal , Rosario González-Muñiz , Gregorio Fernández- Ballester & Antonio Ferrer-Montiel To cite this article: Asia Fernández-Carvajal , Rosario González-Muñiz , Gregorio Fernández- Ballester & Antonio Ferrer-Montiel (2020): Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels, Expert Opinion on Investigational Drugs, DOI: 10.1080/13543784.2020.1825680 To link to this article: https://doi.org/10.1080/13543784.2020.1825680 Published online: 29 Sep 2020. Submit your article to this journal Article views: 31 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ieid20 EXPERT OPINION ON INVESTIGATIONAL DRUGS https://doi.org/10.1080/13543784.2020.1825680 REVIEW Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels Asia Fernández-Carvajala, Rosario González-Muñizb, Gregorio Fernández-Ballestera and Antonio Ferrer-Montiela aInstituto De Investigación, Desarrollo E Innovación En Biotecnología Sanitaria De Elche (Idibe), Universitas Miguel Hernández, Alicante, Spain; bInstituto De Química Médica, CSIC, Madrid, Spain ABSTRACT ARTICLE HISTORY Introduction: Thermo transient receptor potential (thermoTRP) channels are some of the most inten­ Received 15 June 2020 sely pursued therapeutic targets of the past decade. They are considered promising targets of numer­ Accepted 15 September ous diseases including chronic pain and cancer. Modulators of these proteins, in particular TRPV1-4, 2020 TRPM8 and TRPA1, have reached clinical development, but none has been approved for clinical practice KEYWORDS yet.
    [Show full text]
  • Snapshot: Mammalian TRP Channels David E
    SnapShot: Mammalian TRP Channels David E. Clapham HHMI, Children’s Hospital, Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA TRP Activators Inhibitors Putative Interacting Proteins Proposed Functions Activation potentiated by PLC pathways Gd, La TRPC4, TRPC5, calmodulin, TRPC3, Homodimer is a purported stretch-sensitive ion channel; form C1 TRPP1, IP3Rs, caveolin-1, PMCA heteromeric ion channels with TRPC4 or TRPC5 in neurons -/- Pheromone receptor mechanism? Calmodulin, IP3R3, Enkurin, TRPC6 TRPC2 mice respond abnormally to urine-based olfactory C2 cues; pheromone sensing 2+ Diacylglycerol, [Ca ]I, activation potentiated BTP2, flufenamate, Gd, La TRPC1, calmodulin, PLCβ, PLCγ, IP3R, Potential role in vasoregulation and airway regulation C3 by PLC pathways RyR, SERCA, caveolin-1, αSNAP, NCX1 La (100 µM), calmidazolium, activation [Ca2+] , 2-APB, niflumic acid, TRPC1, TRPC5, calmodulin, PLCβ, TRPC4-/- mice have abnormalities in endothelial-based vessel C4 i potentiated by PLC pathways DIDS, La (mM) NHERF1, IP3R permeability La (100 µM), activation potentiated by PLC 2-APB, flufenamate, La (mM) TRPC1, TRPC4, calmodulin, PLCβ, No phenotype yet reported in TRPC5-/- mice; potentially C5 pathways, nitric oxide NHERF1/2, ZO-1, IP3R regulates growth cones and neurite extension 2+ Diacylglycerol, [Ca ]I, 20-HETE, activation 2-APB, amiloride, Cd, La, Gd Calmodulin, TRPC3, TRPC7, FKBP12 Missense mutation in human focal segmental glomerulo- C6 potentiated by PLC pathways sclerosis (FSGS); abnormal vasoregulation in TRPC6-/-
    [Show full text]
  • TRPV4: a Physio and Pathophysiologically Significant Ion Channel
    International Journal of Molecular Sciences Review TRPV4: A Physio and Pathophysiologically Significant Ion Channel Tamara Rosenbaum 1,* , Miguel Benítez-Angeles 1, Raúl Sánchez-Hernández 1, Sara Luz Morales-Lázaro 1, Marcia Hiriart 1 , Luis Eduardo Morales-Buenrostro 2 and Francisco Torres-Quiroz 3 1 Departamento de Neurociencia Cognitiva, División Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico; [email protected] (M.B.-A.); [email protected] (R.S.-H.); [email protected] (S.L.M.-L.); [email protected] (M.H.) 2 Departamento de Nefrología y Metabolismo Mineral, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico; [email protected] 3 Departamento de Bioquímica y Biología Estructural, División Investigación Básica, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico; [email protected] * Correspondence: [email protected]; Tel.: +52-555-622-56-24; Fax: +52-555-622-56-07 Received: 3 May 2020; Accepted: 24 May 2020; Published: 28 May 2020 Abstract: Transient Receptor Potential (TRP) channels are a family of ion channels whose members are distributed among all kinds of animals, from invertebrates to vertebrates. The importance of these molecules is exemplified by the variety of physiological roles they play. Perhaps, the most extensively studied member of this family is the TRPV1 ion channel; nonetheless, the activity of TRPV4 has been associated to several physio and pathophysiological processes, and its dysfunction can lead to severe consequences. Several lines of evidence derived from animal models and even clinical trials in humans highlight TRPV4 as a therapeutic target and as a protein that will receive even more attention in the near future, as will be reviewed here.
    [Show full text]
  • CD95 Ligand - Death Factor and Costimulatory Molecule?
    Cell Death and Differentiation (2003) 10, 1215–1225 & 2003 Nature Publishing Group All rights reserved 1350-9047/03 $25.00 www.nature.com/cdd Review CD95 ligand - death factor and costimulatory molecule? O Janssen*,1, J Qian1, A Linkermann1 and D Kabelitz1 Tissue and Cellular Expression of CD95L 1 Institute for Immunology, Medical Center Schleswig-Holstein, Campus Kiel, Michaelisstrasse 5, D-24105 Kiel, Germany The CD95 ligand (CD95L, Apo-1L, FasL, CD178) is a 281- * Corresponding author: O Janssen. Tel: þ 49-431-5973377; Fax: þ 49-431- amino-acid-containing type II transmembrane protein of the 5973335; E-mail: [email protected] TNF family of death factors (Figure 1).1 Its death-inducing function is best documented in the context of activation- Received 24.4.03; revised 12.6.03; accepted 20.6.03; published online 1 August 2003 induced cell death (AICD) in T cells.2 CD95L is expressed as a Edited by T Ferguson death factor in cytotoxic T lymphocytes (CTL) to kill virally infected or transformed target cells and in natural killer (NK) cells, where it is upregulated by CD16 engagement and 3 Abstract cytokines including IL-2 and IL-12. Similarly, high levels of intracellular CD95L have been detected in monocytic cells The CD95 ligand is involved as a death factor in the with an inducible release upon activation.4 Under physiologi- regulation of activation-induced cell death, establishment cal conditions, CD95L is implicated in the control of erythroid of immune privilege and tumor cell survival. In addition, differentiation,5 angiogenesis in the eye6 and skin home- 7 CD95L may serve as a costimulatory molecule for T-cell ostasis.
    [Show full text]
  • Heteromeric TRP Channels in Lung Inflammation
    cells Review Heteromeric TRP Channels in Lung Inflammation Meryam Zergane 1, Wolfgang M. Kuebler 1,2,3,4,5,* and Laura Michalick 1,2 1 Institute of Physiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; [email protected] (M.Z.); [email protected] (L.M.) 2 German Centre for Cardiovascular Research (DZHK), 10785 Berlin, Germany 3 German Center for Lung Research (DZL), 35392 Gießen, Germany 4 The Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON M5B 1W8, Canada 5 Department of Surgery and Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada * Correspondence: [email protected] Abstract: Activation of Transient Receptor Potential (TRP) channels can disrupt endothelial bar- rier function, as their mediated Ca2+ influx activates the CaM (calmodulin)/MLCK (myosin light chain kinase)-signaling pathway, and thereby rearranges the cytoskeleton, increases endothelial permeability and thus can facilitate activation of inflammatory cells and formation of pulmonary edema. Interestingly, TRP channel subunits can build heterotetramers, whereas heteromeric TRPC1/4, TRPC3/6 and TRPV1/4 are expressed in the lung endothelium and could be targeted as a protec- tive strategy to reduce endothelial permeability in pulmonary inflammation. An update on TRP heteromers and their role in lung inflammation will be provided with this review. Keywords: heteromeric TRP assemblies; pulmonary inflammation; endothelial permeability; TRPC3/6; TRPV1/4; TRPC1/4 Citation: Zergane, M.; Kuebler, W.M.; Michalick, L. Heteromeric TRP Channels in Lung Inflammation. Cells 1. Introduction 2021, 10, 1654. https://doi.org Pulmonary microvascular endothelial cells are a key constituent of the blood air bar- /10.3390/cells10071654 rier that has to be extremely thin (<1 µm) to allow for rapid and efficient alveolo-capillary gas exchange.
    [Show full text]
  • Ca Signaling in Cardiac Fibroblasts and Fibrosis-Associated Heart
    Journal of Cardiovascular Development and Disease Review Ca2+ Signaling in Cardiac Fibroblasts and Fibrosis-Associated Heart Diseases Jianlin Feng 1, Maria K. Armillei 1, Albert S. Yu 1, Bruce T. Liang 1, Loren W. Runnels 2,* and Lixia Yue 1,* 1 Calhoun Cardiology Center, Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030, USA; [email protected] (J.F.); [email protected] (M.K.A.); [email protected] (A.S.Y.); [email protected] (B.T.L.) 2 Department of Pharmacology, Rutgers, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA * Correspondence: [email protected] (L.W.R.); [email protected] (L.Y.) Received: 11 August 2019; Accepted: 18 September 2019; Published: 23 September 2019 Abstract: Cardiac fibrosis is the excessive deposition of extracellular matrix proteins by cardiac fibroblasts and myofibroblasts, and is a hallmark feature of most heart diseases, including arrhythmia, hypertrophy, and heart failure. This maladaptive process occurs in response to a variety of stimuli, including myocardial injury, inflammation, and mechanical overload. There are multiple signaling pathways and various cell types that influence the fibrogenesis cascade. Fibroblasts and myofibroblasts are central effectors. Although it is clear that Ca2+ signaling plays a vital role in this pathological process, what contributes to Ca2+ signaling in fibroblasts and myofibroblasts is still not wholly understood, chiefly because of the large and diverse number of receptors, transporters, and ion channels that influence intracellular Ca2+ signaling. Intracellular Ca2+ signals are generated by Ca2+ release from intracellular Ca2+ stores and by Ca2+ entry through a multitude of Ca2+-permeable ion channels in the plasma membrane.
    [Show full text]
  • (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis
    Hindawi Journal of Immunology Research Volume 2020, Article ID 2906845, 11 pages https://doi.org/10.1155/2020/2906845 Research Article TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis Joel J. Toledo Mauriño,1,2 Gabriela Fonseca-Camarillo ,1 Janette Furuzawa-Carballeda ,3 Rafael Barreto-Zuñiga,4 Braulio Martínez Benítez ,5 Julio Granados ,6 and Jesus K. Yamamoto-Furusho 1 1Inflammatory Bowel Disease Clinic. Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico 2MD/PhD Program (PECEM), Facultad de Medicina, Universidad Nacional Autónoma de México, Av. Ciudad Universitaria 3000, C.P. 04360 Coyoacán, México City, Mexico 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico 4Department of Endoscopy, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico 5Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico 6Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Correspondence should be addressed to Jesus K. Yamamoto-Furusho; [email protected] Received 25 October 2019; Revised 4 March 2020; Accepted 11 April 2020; Published 8 May 2020 Academic Editor: Francesca Santilli Copyright © 2020 Joel J. Toledo Mauriño et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. TRPVs are a group of receptors with a channel activity predominantly permeable to Ca2+. This subfamily is involved in the development of gastrointestinal diseases such as ulcerative colitis (UC).
    [Show full text]
  • Transient Receptor Potential Cation Channel Subfamily V and Breast Cancer
    Laboratory Investigation (2020) 100:199–206 https://doi.org/10.1038/s41374-019-0348-0 REVIEW ARTICLE Transient receptor potential cation channel subfamily V and breast cancer 1 2 1,3,4 Choon Leng So ● Michael J. G. Milevskiy ● Gregory R. Monteith Received: 27 September 2019 / Revised: 13 November 2019 / Accepted: 14 November 2019 / Published online: 10 December 2019 © The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2019 Abstract Transient receptor potential cation channel subfamily V (TRPV) channels play important roles in a variety of cellular processes. One example includes the sensory role of TRPV1 that is sensitive to elevated temperatures and acidic environments and is activated by the hot pepper component capsaicin. Another example is the importance of the highly Ca2+ selective channels TRPV5 and TRPV6 in Ca2+ absorption/reabsorption in the intestine and kidney. However, in some cases such as TRPV4 and TRPV6, breast cancer cells appear to overexpress TRPV channels. Moreover, TRPV mediated Ca2+ influx may contribute to enhanced breast cancer cell proliferation and other processes important in tumor progression such as angiogenesis. It appears that the overexpression of some TRPV channels in breast cancer and/or their involvement in breast 1234567890();,: 1234567890();,: cancer cell processes, processes important in the tumor microenvironment or pain may make some TRPV channels potential targets for breast cancer therapy. In this review, we provide an overview of TRPV expression in breast cancer subtypes, the roles of TRPV channels in various aspects of breast cancer progression and consider implications for future therapeutic approaches. Introduction [1]. TRP channel protein subunits have six transmembrane domains that form tetramers to create the ion channel [1, 2].
    [Show full text]
  • Supplementary Material Contents
    Supplementary Material Contents Immune modulating proteins identified from exosomal samples.....................................................................2 Figure S1: Overlap between exosomal and soluble proteomes.................................................................................... 4 Bacterial strains:..............................................................................................................................................4 Figure S2: Variability between subjects of effects of exosomes on BL21-lux growth.................................................... 5 Figure S3: Early effects of exosomes on growth of BL21 E. coli .................................................................................... 5 Figure S4: Exosomal Lysis............................................................................................................................................ 6 Figure S5: Effect of pH on exosomal action.................................................................................................................. 7 Figure S6: Effect of exosomes on growth of UPEC (pH = 6.5) suspended in exosome-depleted urine supernatant ....... 8 Effective exosomal concentration....................................................................................................................8 Figure S7: Sample constitution for luminometry experiments..................................................................................... 8 Figure S8: Determining effective concentration .........................................................................................................
    [Show full text]